Follow the Zura Bio Ltd stock price and the full management transaction log of the company, a listed equity based in United States. Shares are quoted on the US market, under the authority of SEC (Form 4). Market capitalisation: €328.7m. The latest transaction was disclosed on 2 March 2026 (Acquisition). Among the most active insiders: Howell Michael. All data is openly available.
21
Insider Decl.
n/a
Thresholds
€15m
7 ops.
Buy Volume
€20m
4 ops.
Sell Volume
41Σ signal
Buys €15m€20m Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
2,337,630 sharesClass A ordinary sharesSEC:0001104659-23-035745:0
21 of 21 declarations
Acerca de Zura Bio Ltd
Zura Bio Ltd es una empresa de biotecnología centrada en el desarrollo de tratamientos innovadores para enfermedades autoinmunes. Cotiza en NASDAQ bajo el símbolo ZURA.